Citation: | ZHA Qian, GAO Xiangdong, CHEN Song. Effects of VHL inhibitor on rotenone-induced Caenorhabditis elegans model of Parkinson′s disease[J]. Journal of China Pharmaceutical University, 2021, 52(3): 346-351. DOI: 10.11665/j.issn.1000-5048.20210312 |
[1] |
. JAMA,2020,323(6):548-560.
|
[2] |
Martinez BA,Petersen DA,Gaeta AL,et al. Dysregulation of the mitochondrial unfolded protein response induces non-apoptotic dopaminergic neurodegeneration in C. elegans models of Parkinson''s disease[J]. J Neurosci,2017,37(46):11085-11100.
|
[3] |
Runkel ED,Liu S,Baumeister R,et al. Surveillance-activated defenses block the ROS-induced mitochondrial unfolded protein response[J]. PLoS Genet,2013,9(3):
|
[4] |
Schmidt E,Seifert M,Baumeister R. Caenorhabditis elegans as a model system for Parkinson''s disease[J]. Neurodegener Dis,2007,4(2/3):199-217.
|
[5] |
Shaye DD,Greenwald I. OrthoList:a compendium of C. elegans genes with human orthologs[J]. PLoS One,2011,6(5):
|
[6] |
Kaletta T,Hengartner MO. Finding function in novel targets:C. elegans as a model organism[J]. Nat Rev Drug Discov,2006,5(5):387-398.
|
[7] |
Culetto E,Sattelle DB. A role for Caenorhabditis elegans in understanding the function and interactions of human disease genes[J]. Hum Mol Genet,2000,9(6):869-877.
|
[8] |
Harrington AJ,Hamamichi S,Caldwell GA,et al. C. elegans as a model organism to investigate molecular pathways involved with Parkinson''s disease[J]. Dev Dyn,2010,239(5):1282-1295.
|
[9] |
Li J,Le WD. Modeling neurodegenerative diseases in Caenorhabditis elegans[J]. Exp Neurol,2013,250:94-103.
|
[10] |
González-Hunt CP,Leung MC,Bodhicharla RK,et al. Exposure to mitochondrial genotoxins and dopaminergic neurodegeneration in Caenorhabditis elegans[J]. PLoS One,2014,9(12):
|
[11] |
Lehtonen ?,Jaronen M,Vehvil?inen P,et al. Inhibition of excessive oxidative protein folding is protective in MPP(+) toxicity-induced Parkinson''s disease models[J]. Antioxid Redox Signal,2016,25(8):485-497.
|
[12] |
Cooper JF,Dues DJ,Spielbauer KK,et al. Delaying aging is neuroprotective in Parkinson''s disease:a genetic analysis in C. elegans models[J]. NPJ Parkinsons Dis,2015,1:15022.
|
[13] |
Chen S,Luo S,Zhang Z,et al. VHL-1 inactivation and mitochondrial antioxidants rescue C. elegans dopaminergic neurodegeneration[J]. Protein Cell,2019,10(8):610-614.
|
[14] |
Stiernagle T. Maintenance of C. elegans[J]. WormBook,2006,11:1-11.
|
[15] |
Brenner S. The genetics of Caenorhabditis elegans[J]. Genetics,1974,77(1):71-94.
|
[16] |
Cao X,Wang X,Chen H,et al. Neurotoxicity of nonylphenol exposure on Caenorhabditis elegans induced by reactive oxidative species and disturbance synthesis of serotonin[J]. Environ Pollut,2019,244:947-957.
|
[17] |
Tsai CW,Tsai RT,Liu SP,et al. Neuroprotective effects of betulin in pharmacological and transgenic Caenorhabditis elegans models of Parkinson''s disease[J]. Cell Transplant,2017,26(12):1903-1918.
|
[1] | YU Juping, LIU Wei, YE Meng, TANG Dongyang, GAO Xiangdong. Effect of homologous overexpression of nucleoside diphosphate kinase on the yield and molecular weight of hyaluronic acid[J]. Journal of China Pharmaceutical University, 2022, 53(2): 232-238. DOI: 10.11665/j.issn.1000-5048.20220214 |
[2] | JIANG Liya, LUO Ping, DENG Shaorong, YE Hao, YU Yan, HAN Wei. Antitumor effect of recombinant mouse interleukin-33 in mice[J]. Journal of China Pharmaceutical University, 2020, 51(5): 584-590. DOI: 10.11665/j.issn.1000-5048.20200510 |
[3] | LI Chengfei, CHEN Ling, WU Xuri. Regio-selective glycosylation of mogroside IIIE by glycosyltransferase[J]. Journal of China Pharmaceutical University, 2019, 50(2): 222-229. DOI: 10.11665/j.issn.1000-5048.20190214 |
[4] | JIN Yue, WU Xuri, CHEN Yijun. Applications of glycosyltransferases in the improvement of druggability of natural products[J]. Journal of China Pharmaceutical University, 2017, 48(5): 529-535. DOI: 10.11665/j.issn.1000-5048.20170504 |
[5] | XIA Yang, HU Lingling, CHEN Jiao, LU Wuguang, YAN Huaijiang, HUO Jiege, CAO Peng. Cloning and expression of recombinant BmkNaTx12, a new voltage-gated sodium channel from scorpion Buthus martensii Karsch[J]. Journal of China Pharmaceutical University, 2017, 48(2): 220-226. DOI: 10.11665/j.issn.1000-5048.20170214 |
[6] | WANG Yuanxi, CHEN Junsheng, SHAO Lei, LI Ji′an, LIN Huimin, CHEN Daijie. Heterologous expression and in vitro activity of vancomycin glycosyltransferase GtfE[J]. Journal of China Pharmaceutical University, 2013, 44(3): 272-276. DOI: 10.11665/j.issn.1000-5048.20130317 |
[7] | ZHAO Na, SUN Hong-bin. Poly(ADP-ribose) polymerase inhibitors and synthetic lethality[J]. Journal of China Pharmaceutical University, 2012, 43(2): 107-112. |
[8] | LIN Yu-shuang, HONG Wen-rong. Construction of Streptomyces tenebrarius mutant with knockout of tobS1-C genes[J]. Journal of China Pharmaceutical University, 2012, 43(1): 92-96. |
[9] | Construction of a high epidaunorubicin-producing strain by gene recombination[J]. Journal of China Pharmaceutical University, 2010, 41(3): 283-288. |
[10] | PENG Chen, GE Hao, HE Shu-ying, GAO Xiang-dong. Molecular cloning,expression and identification of recombinant hyaluronan synthase from Pasteurella multocida[J]. Journal of China Pharmaceutical University, 2009, 40(6): 549-552. |
1. |
马小翔,马泽源,刘亚月,周龙建,和羿帆,张翼. 仿突变生物合成调控对土曲霉C23-3次生代谢产物的影响. 生物技术通报. 2024(08): 275-287 .
![]() |